CN103960731B - 一种含门冬氨酸鸟氨酸的饮品及其制备方法 - Google Patents
一种含门冬氨酸鸟氨酸的饮品及其制备方法 Download PDFInfo
- Publication number
- CN103960731B CN103960731B CN201310034988.9A CN201310034988A CN103960731B CN 103960731 B CN103960731 B CN 103960731B CN 201310034988 A CN201310034988 A CN 201310034988A CN 103960731 B CN103960731 B CN 103960731B
- Authority
- CN
- China
- Prior art keywords
- drink
- milk
- yoghourt
- fruit juice
- aspartic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 title claims abstract description 22
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 title claims abstract description 22
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 229960003104 ornithine Drugs 0.000 title claims abstract description 22
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 title claims abstract description 20
- 235000003704 aspartic acid Nutrition 0.000 title claims abstract description 20
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title abstract description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 30
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 20
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 10
- 235000012907 honey Nutrition 0.000 claims abstract description 10
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 10
- 239000004310 lactic acid Substances 0.000 claims abstract description 10
- 235000002906 tartaric acid Nutrition 0.000 claims abstract description 10
- 239000011975 tartaric acid Substances 0.000 claims abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 9
- 239000008103 glucose Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 235000015203 fruit juice Nutrition 0.000 claims description 15
- 235000013336 milk Nutrition 0.000 claims description 15
- 239000008267 milk Substances 0.000 claims description 15
- 210000004080 milk Anatomy 0.000 claims description 15
- 235000013618 yogurt Nutrition 0.000 claims description 14
- 235000015165 citric acid Nutrition 0.000 claims description 9
- 235000001727 glucose Nutrition 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000005374 membrane filtration Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000010792 warming Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims description 2
- 210000004185 liver Anatomy 0.000 abstract description 10
- 230000035622 drinking Effects 0.000 abstract description 3
- 210000005229 liver cell Anatomy 0.000 abstract description 3
- 231100000614 poison Toxicity 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 2
- 239000003440 toxic substance Substances 0.000 abstract description 2
- 208000010706 fatty liver disease Diseases 0.000 description 6
- 208000004930 Fatty Liver Diseases 0.000 description 5
- 206010019708 Hepatic steatosis Diseases 0.000 description 5
- 231100000240 steatosis hepatitis Toxicity 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000024798 heartburn Diseases 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000002747 voluntary effect Effects 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N Aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010016262 Fatty liver alcoholic Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000026594 alcoholic fatty liver disease Diseases 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N keto-D-fructose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 230000004143 urea cycle Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明涉及一种含门冬氨酸鸟氨酸的饮品及其制备方法。该饮品包括以下重量百分比的成分：门冬氨酸鸟氨酸0.1-30%、酒石酸0.01-3%、白砂糖0.1-10%、葡萄糖0.1-10%、柠檬酸0.01-3%、乳酸0.01-10%、蜂蜜0.01-10%，余量为纯净水。本发明进一步公开了该饮品的制备方法。本发明饮品口感好适于日常饮用，具有修复损伤的肝细胞、保护肝脏的功效，可护肝、解毒、缓解醉酒。
Description
技术领域
本发明涉及保健食品领域，具体涉及一种含门冬氨酸鸟氨酸的复合配方饮品及其制备方法，属于含门冬氨酸鸟氨酸的饮品领域。
背景技术
由于现代人生活节奏快，工作压力大，过度劳累，缺乏运动，应酬喝酒的场合多，导致很多人肝脏负担大，发生肥胖性脂肪肝、酒精性脂肪肝等，肝脏长期处于损伤状态。并且中国目前是病毒性肝炎发病大国，许多患者需要服用抗病毒药物，但是这样肝脏除了负担营养物质的转化工作外还要担负解除药物毒性的重任，而肝脏被病毒感染后，不仅难以完成药物的解毒重任，还有可能产生药物性肝损伤，加速肝组织纤维化。因此目前需要一种既不增加肝脏负担、又能有利于损伤的肝细胞修复、保护肝脏并且口感好适于日常饮用的饮品。
发明内容
为了解决以上技术问题，本发明提供一种含门冬氨酸鸟氨酸的饮品，饮用后可缓解肝炎、脂肪肝，可解肝毒、缓解醉酒症状并且口感好。
本发明的技术方案如下：
一种含门冬氨酸鸟氨酸的饮品，该饮品包括以下重量百分比的成分：门冬氨酸鸟氨酸0.1-30%、酒石酸0.01-3%、白砂糖0.1-10%、葡萄糖0.1-10%、柠檬酸0.01-3%、乳酸0.01-10%、蜂蜜0.01-10%，余量为纯净水。
优选的，该饮品还包括果汁、牛奶或酸奶中的一种或一种以上。
优选的，所述果汁、牛奶或酸奶的重量百分比分别为1-99%。
还提供了一种含门冬氨酸鸟氨酸的饮品的制备方法，包括：
（1）将门冬氨酸鸟氨酸、酒石酸、白砂糖、葡萄糖、柠檬酸、乳酸、蜂蜜、果汁、牛奶和酸奶倒入纯净水中混匀加热升温至充分溶解；（2）滤膜过滤，滤液灭菌，分装，即得。
优选的，步骤（1）中所述的升温是将混合溶液的温度升温至40-50℃。
优选的，步骤（2）中所述的灭菌是将滤液温度升到62~65℃，保持30分钟。
所述滤膜为孔径范围为0.15μm至2.0μm的滤膜。
本发明提供的含门冬氨酸鸟氨酸的饮品被饮用后分解出的鸟氨酸几乎参与了尿素循环活化和氨解毒的全过程，促进氨甲酰磷酸合成酶及谷氨酰胺的合成，增加了肝脏的解毒功能，改善支链氨基酸与芳香氨基酸的比值，临床上可显著降低血氨；门冬氨酸则参与肝细胞内谷氨酰胺和核酸合成，可促进肝脏内谷氨酰胺合成，又间接参与三羧酸循环合成，并提供能量代谢的中间产物，改善肝脏功能，加速受损肝细胞的自我修复和再生过程。除此之外，由于加入了白砂糖、果汁、牛奶或者酸奶等调味成分，使本饮品口感好，果汁、蜂蜜及牛奶为本饮品进一步提供人体所需要的营养成分，提供日常所需能量。乳酸、酒石酸和柠檬酸等有机酸的加入既起到调节产品酸度改善口味的效果又能与乙醇反应生成酯类物质，缓解醉酒后的不适症状。
具体实施方式
下面结合实施例对本发明的技术方案进行详细描述。
实施例1:将重量百分比为64.12%的纯净水倒入配料罐中，然后加入门冬氨酸鸟氨酸使其含量为0.6％，酒石酸为0.06%，柠檬酸为0.06%，葡萄糖为1.2%，白砂糖为1.8%，乳酸为0.06%，蜂蜜为0.3%，最后加入果汁12.7%，牛奶12.7%、酸奶6.4%。加入完毕后逐渐加热升温至40℃边搅拌边升温直至充分混匀为止，再用0.8μm滤膜过滤，过滤后将温度升至62℃，保持30分钟进行灭菌，最后分装。
实施例2:将重量百分比为84.98%的纯净水倒入配料罐，然后加入门冬氨酸鸟氨酸使其含量为0.45%，酒石酸为0.09%，柠檬酸为0.09%，葡萄糖为1.8%，白砂糖为2.7%，乳酸为0.09%，蜂蜜为0.9%，最后只加入果汁使其含量为8.9%。加入完毕后逐渐加热升温至50℃边搅拌边升温直至充分混匀为止，再用0.22μm或者2.0μm滤膜过滤，过滤后将温度升至65℃，保持30分钟进行灭菌，最后分装。
实施例3:将重量百分比为84.88%的纯净水倒入配料罐，然后加入门冬氨酸鸟氨酸使其含量为0.45%，酒石酸为0.09%，柠檬酸为0.09%，葡萄糖为1.8%，白砂糖为2.7%，乳酸为0.09%，蜂蜜为0.9%，最后只加入牛奶使其含量为9%。加入完毕后逐渐加热升温至45℃边搅拌边升温直至充分混匀为止，再用0.8μm滤膜过滤，过滤后将温度升至到64℃，保持30分钟进行灭菌，最后分装。
实施例4:将重量百分比为84.93%的纯净水倒入配料罐，然后加入门冬氨酸鸟氨酸使其含量为0.45%，酒石酸为0.09%，柠檬酸为0.04%，葡萄糖为1.8%，白砂糖为2.7%，乳酸为0.09%，蜂蜜为0.9%，最后只加入酸奶使其含量为9%。加入完毕后逐渐加热升温至42℃边搅拌边升温直至充分混匀为止，再用0.8μm滤膜过滤，过滤后将温度升至到63℃，保持30分钟进行灭菌，最后分装。
实施例5：缓解肝炎、脂肪肝的实验数据如下：
选取10名轻度肝炎患者和15名脂肪肝患者作为自愿被试志愿者，1月内每天饮用本发明的饮品两瓶，每瓶300ml，之后经医院检查后脂肪肝患者病情改善者53.3%，肝功能指数（谷草转氨酶AST、谷丙转氨酶ALT）下降的患者48%。
实施例6：缓解醉酒后不适症状实验数据如下：
选取10名自愿被试志愿者，每人在1小时内喝下56度白酒150ml，期间不食用其他食物或饮料，9名被试者出现不同程度的恶心、头晕、胃灼烧感等，之后分别提供其饮用本发明的饮品300ml，饮用完本饮品半小时之后询问其不适症状，其中77.8%的人胃灼烧感减轻，88.9%的人恶心症状减轻，55.6%的人头晕症状减轻。
最后所应说明的是，以上实施例仅用以说明本材料的技术实施方案而非限制，尽管参照较佳实施例对本发明进行了详细说明，本领域的普通技术人员应当理解，可以对本发明的技术方案进行修改或者等同替换，而不脱离本发明技术方案的精神和范围，其均应涵盖在本发明的权利要求范围当中。
Claims (6)
1.一种含门冬氨酸鸟氨酸的饮品，其特征在于：该饮品包括以下重量百分比的成分：门冬氨酸鸟氨酸0.1-30％、酒石酸0.01-3％、白砂糖0.1-10％、葡萄糖0.1-10％、柠檬酸0.01-3％、乳酸0.01-10％、蜂蜜0.01-10％，还包括果汁、牛奶或酸奶中的一种或一种以上，余量为纯净水。
2.如权利要求1所述的含门冬氨酸鸟氨酸的饮品，其特征在于：当饮品中还包括果汁、牛奶或酸奶中的一种时，所述果汁、牛奶或酸奶的重量百分比为1-99％；当饮品中还包括果汁、牛奶或酸奶中的一种以上时，所述果汁和牛奶、果汁和酸奶、牛奶和酸奶或果汁牛奶和酸奶的重量百分比之和为1-99％。
3.一种制备权利要求1所述的含门冬氨酸鸟氨酸的饮品的方法，其特征在于，包括：(1)将门冬氨酸鸟氨酸、酒石酸、白砂糖、葡萄糖、柠檬酸、乳酸、蜂蜜倒入纯净水中，最后加入果汁、牛奶或酸奶中的一种或一种以上，混匀加热升温至充分溶解；(2)滤膜过滤，滤液灭菌，分装，即得。
4.按照权利要求3所述的方法，其特征在于：步骤(1)中所述的升温是升温至40-50℃。
5.按照权利要求3所述的方法，其特征在于：步骤(2)中所述的灭菌是将滤液温度升到62～65℃，保持30分钟。
6.按照权利要求3所述的的方法，其特征在于：所述滤膜为孔径范围为0.15μm至2.0μm的滤膜。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310034988.9A CN103960731B (zh) | 2013-01-30 | 2013-01-30 | 一种含门冬氨酸鸟氨酸的饮品及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310034988.9A CN103960731B (zh) | 2013-01-30 | 2013-01-30 | 一种含门冬氨酸鸟氨酸的饮品及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103960731A CN103960731A (zh) | 2014-08-06 |
| CN103960731B true CN103960731B (zh) | 2016-04-27 |
Family
ID=51231136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310034988.9A Active CN103960731B (zh) | 2013-01-30 | 2013-01-30 | 一种含门冬氨酸鸟氨酸的饮品及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103960731B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105795278A (zh) * | 2014-12-27 | 2016-07-27 | 辽宁药联制药有限公司 | 一种门冬氨酸钾饮品及其制备方法 |
| AU2016299246B2 (en) * | 2015-07-24 | 2021-10-21 | Evonik Operations Gmbh | Effervescent formulations of ornithine aspartate |
| EP3372578A4 (en) | 2015-11-02 | 2019-11-13 | Adabio Co.,Ltd. | NOVEL CITRIC ACID DERIVATIVE |
| CN106418069A (zh) * | 2016-09-12 | 2017-02-22 | 福建万亿店中店电子商务有限责任公司 | 一种具有解酒保肝功效的饮品 |
| CN115397263B (zh) * | 2021-01-29 | 2023-04-14 | 张曼 | 一种包含n-乙酰氨基葡萄糖的组合物及其制备方法和应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3669689A (en) * | 1963-07-30 | 1972-06-13 | Kyowa Hakko Kogyo Kk | Fortification of food or alcoholic beverages with copolypeptides |
| WO2011083556A1 (ja) * | 2010-01-08 | 2011-07-14 | キリンホールディングス株式会社 | 高香味オルニチン入り無アルコール麦芽飲料 |
-
2013
- 2013-01-30 CN CN201310034988.9A patent/CN103960731B/zh active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3669689A (en) * | 1963-07-30 | 1972-06-13 | Kyowa Hakko Kogyo Kk | Fortification of food or alcoholic beverages with copolypeptides |
| WO2011083556A1 (ja) * | 2010-01-08 | 2011-07-14 | キリンホールディングス株式会社 | 高香味オルニチン入り無アルコール麦芽飲料 |
| JP2011139687A (ja) * | 2010-01-08 | 2011-07-21 | Kirin Holdings Co Ltd | 高香味オルニチン入り無アルコール麦芽飲料 |
| TW201138647A (en) * | 2010-01-08 | 2011-11-16 | Kirin Holdings Kk | Highly flavored ornithine-containing alcohol-free malt beverage |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103960731A (zh) | 2014-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103960731B (zh) | 一种含门冬氨酸鸟氨酸的饮品及其制备方法 | |
| CN104256625B (zh) | 一种解酒酵素及其生产工艺 | |
| KR20160040151A (ko) | 기능성 발효 탄산음료, 발효 술, 화장품 원료, 발효 및 제조방법 | |
| CN103284242A (zh) | 一种解酒饮品 | |
| CN104171774A (zh) | 一种酶解风味金柚膏及其制作方法 | |
| CN103230071B (zh) | 醋蛋蜂蜜膏的制备方法 | |
| CN105707876B (zh) | 一种具有稳定和溶解斑块的饮食组合物及其制备方法和用途 | |
| CN101361513B (zh) | 防治高血压的中草药活菌茶饮品及其制备方法 | |
| CN102919834B (zh) | 一种谷胱甘肽解酒食品 | |
| CN101792703A (zh) | 一种滇橄榄茶酒及其制备方法 | |
| CN104643201A (zh) | 解酒饮料 | |
| CN103621871B (zh) | 一种复合氨基酸保健品及其制备方法 | |
| CN103110152A (zh) | 保健饮料的制备方法 | |
| CN102823862A (zh) | 一种用于气虚体质的组合物及其制备方法和用途 | |
| CN102008103B (zh) | 一种保健饮料及其制备方法 | |
| CN107904061A (zh) | 一种助眠红酒果酒及其制作方法 | |
| CN1748552B (zh) | 一种保健蜂蜜浓汁 | |
| CN103666972B (zh) | 西瓜葡萄红枣枸杞酒饮料 | |
| CN102994299A (zh) | 一种保健葡萄酒的制作方法 | |
| CN102978101A (zh) | 一种和中消食水果醋的加工方法 | |
| CN101586071A (zh) | 罗汉果醋 | |
| CN105685747B (zh) | 一种触变性饮料及其制备方法 | |
| CN107753570A (zh) | 一种具有消肿止痛功效的药酒 | |
| CN101978998B (zh) | 解酒护肝药物组合物及制备方法 | |
| CN107788301A (zh) | 一种核桃椰子复合型发酵饮料及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |